These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 22689975

  • 21. Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB.
    De Pasquale V, Scerra G, Scarcella M, D'Agostino M, Pavone LM.
    Biochim Biophys Acta Mol Cell Res; 2021 Oct; 1868(11):119113. PubMed ID: 34329663
    [Abstract] [Full Text] [Related]

  • 22. Analysis of the biogenesis of heparan sulfate acetyl-CoA:alpha-glucosaminide N-acetyltransferase provides insights into the mechanism underlying its complete deficiency in mucopolysaccharidosis IIIC.
    Durand S, Feldhammer M, Bonneil E, Thibault P, Pshezhetsky AV.
    J Biol Chem; 2010 Oct 08; 285(41):31233-42. PubMed ID: 20650889
    [Abstract] [Full Text] [Related]

  • 23. Heparin/heparan sulfate 6-O-sulfatase from Flavobacterium heparinum: integrated structural and biochemical investigation of enzyme active site and substrate specificity.
    Myette JR, Soundararajan V, Shriver Z, Raman R, Sasisekharan R.
    J Biol Chem; 2009 Dec 11; 284(50):35177-88. PubMed ID: 19726671
    [Abstract] [Full Text] [Related]

  • 24. The Enzymatic Degradation of Heparan Sulfate.
    Griffin LS, Gloster TM.
    Protein Pept Lett; 2017 Dec 11; 24(8):710-722. PubMed ID: 28741461
    [Abstract] [Full Text] [Related]

  • 25. Novel subtype of mucopolysaccharidosis caused by arylsulfatase K (ARSK) deficiency.
    Verheyen S, Blatterer J, Speicher MR, Bhavani GS, Boons GJ, Ilse MB, Andrae D, Sproß J, Vaz FM, Kircher SG, Posch-Pertl L, Baumgartner D, Lübke T, Shah H, Al Kaissi A, Girisha KM, Plecko B.
    J Med Genet; 2022 Oct 11; 59(10):957-964. PubMed ID: 34916232
    [Abstract] [Full Text] [Related]

  • 26. Enhancement of residual arylsulfatase B activity in feline mucopolysaccharidosis VI by thiol-induced subunit association.
    Vine DT, McGovern MM, Schuchman EH, Haskins ME, Desnick RJ.
    J Clin Invest; 1982 Feb 11; 69(2):294-302. PubMed ID: 6799547
    [Abstract] [Full Text] [Related]

  • 27. A genetic model of substrate reduction therapy for mucopolysaccharidosis.
    Lamanna WC, Lawrence R, Sarrazin S, Lameda-Diaz C, Gordts PL, Moremen KW, Esko JD.
    J Biol Chem; 2012 Oct 19; 287(43):36283-90. PubMed ID: 22952226
    [Abstract] [Full Text] [Related]

  • 28. Crosstalk between 2 organelles: Lysosomal storage of heparan sulfate causes mitochondrial defects and neuronal death in mucopolysaccharidosis III type C.
    Pshezhetsky AV.
    Rare Dis; 2015 Oct 19; 3(1):e1049793. PubMed ID: 26459666
    [Abstract] [Full Text] [Related]

  • 29. Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics.
    Jones MZ, Alroy J, Boyer PJ, Cavanagh KT, Johnson K, Gage D, Vorro J, Render JA, Common RS, Leedle RA, Lowrie C, Sharp P, Liour SS, Levene B, Hoard H, Lucas R, Hopwood JJ.
    J Neuropathol Exp Neurol; 1998 Feb 19; 57(2):148-57. PubMed ID: 9600207
    [Abstract] [Full Text] [Related]

  • 30. Activities of sulfatases for the degradation of acidic glycosaminoglycans in cultured skin fibroblasts from two siblings with multiple sulfatase deficiency.
    Minami R, Fujibayashi S, Tachi N, Wagatsuma K, Nakao T, Ikeno T, Tsugawa S, Sukegawa K, Orii T.
    Clin Chim Acta; 1983 Apr 19; 129(2):175-80. PubMed ID: 6851160
    [Abstract] [Full Text] [Related]

  • 31. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
    Kubaski F, Suzuki Y, Orii K, Giugliani R, Church HJ, Mason RW, Dũng VC, Ngoc CT, Yamaguchi S, Kobayashi H, Girisha KM, Fukao T, Orii T, Tomatsu S.
    Mol Genet Metab; 2017 Mar 19; 120(3):247-254. PubMed ID: 28065440
    [Abstract] [Full Text] [Related]

  • 32. Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses.
    De Pasquale V, Sarogni P, Pistorio V, Cerulo G, Paladino S, Pavone LM.
    Mol Ther Methods Clin Dev; 2018 Sep 21; 10():8-16. PubMed ID: 29942826
    [Abstract] [Full Text] [Related]

  • 33. Lysosomal (leucocyte) proteinase and sulfatase levels in Dyggve-Melchior-Clausen (DMC) syndrome.
    Rastogi SC, Clausen J, Melchior JC, Dyggve HV, Jensen GE.
    Acta Neurol Scand; 1977 Nov 21; 56(5):389-96. PubMed ID: 74186
    [Abstract] [Full Text] [Related]

  • 34. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes.
    Toma L, Dietrich CP, Nader HB.
    Lab Invest; 1996 Dec 21; 75(6):771-81. PubMed ID: 8973472
    [Abstract] [Full Text] [Related]

  • 35. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H, Wood T, Young SP, Millington DS.
    Mol Genet Metab; 2015 Feb 21; 114(2):123-8. PubMed ID: 25458519
    [Abstract] [Full Text] [Related]

  • 36. alpha-L-iduronidase, beta-D-glucuronidase, and 2-sulfo-L-iduronate 2-sulfatase: preparation and characterization of radioactive substrates from heparin.
    Hopwood JJ.
    Carbohydr Res; 1979 Mar 21; 69():203-16. PubMed ID: 106967
    [Abstract] [Full Text] [Related]

  • 37. Caprine mucopolysaccharidosis IIID: a preliminary trial of enzyme replacement therapy.
    Downs-Kelly E, Jones MZ, Alroy J, Cavanagh KT, King B, Lucas RE, Baker JC, Kraemer SA, Hopwood JJ.
    J Mol Neurosci; 2000 Dec 21; 15(3):251-62. PubMed ID: 11303788
    [Abstract] [Full Text] [Related]

  • 38. Deficiency of chondroitin sulfate N-acetylgalactosamine 4-sulfate sulfatase in Maroteaux-Lamy syndrome.
    Matalon R, Arbogast B, Dorfman A.
    Biochem Biophys Res Commun; 1974 Dec 23; 61(4):1450-7. PubMed ID: 4218107
    [No Abstract] [Full Text] [Related]

  • 39. Leukocyte Imbalances in Mucopolysaccharidoses Patients.
    Lopes N, Maia ML, Pereira CS, Mondragão-Rodrigues I, Martins E, Ribeiro R, Gaspar A, Aguiar P, Garcia P, Cardoso MT, Rodrigues E, Leão-Teles E, Giugliani R, Coutinho MF, Alves S, Macedo MF.
    Biomedicines; 2023 Jun 13; 11(6):. PubMed ID: 37371793
    [Abstract] [Full Text] [Related]

  • 40. Arylsulfatase K, a novel lysosomal sulfatase.
    Wiegmann EM, Westendorf E, Kalus I, Pringle TH, Lübke T, Dierks T.
    J Biol Chem; 2013 Oct 18; 288(42):30019-30028. PubMed ID: 23986440
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.